Sign In
Get Clay Free →

Miquel Vila-Perello

CEO at Splice Bio

Miquel Vila-Perelló is an experienced executive, project leader, and researcher in the biotechnology industry. He holds a Doctor of Philosophy (Ph.D.) in Chemistry and a Master's Degree in Organic Chemistry from Universitat de Barcelona.

Throughout his career, Miquel has held various key positions including CEO at Splice Bio, former CEO and CSO at ProteoDesign, and roles as a Research Scholar at Princeton University, Postdoctoral Associate and Fellow at Rockefeller University, and a Postdoctoral Fellow at Universitat Pompeu Fabra. He also started his academic journey as a Graduate student at Universitat de Barcelona.

Highlights

Oct 17 · PR Newswire
SpliceBio Enters Collaboration with Spark Therapeutics to Develop ... - PR Newswire
Jun 20 · Yahoo Finance
SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program - Yahoo Finance
SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Developmen
M
Get intro to Miquel
Add to my network

Location

Barcelona, Catalonia, Spain

Miquel Vila-Perello

CEO at Splice Bio

M
Get intro to Miquel
Add to my network

Location

Barcelona, Catalonia, Spain

Miquel Vila-Perelló is an experienced executive, project leader, and researcher in the biotechnology industry. He holds a Doctor of Philosophy (Ph.D.) in Chemistry and a Master's Degree in Organic Chemistry from Universitat de Barcelona.

Throughout his career, Miquel has held various key positions including CEO at Splice Bio, former CEO and CSO at ProteoDesign, and roles as a Research Scholar at Princeton University, Postdoctoral Associate and Fellow at Rockefeller University, and a Postdoctoral Fellow at Universitat Pompeu Fabra. He also started his academic journey as a Graduate student at Universitat de Barcelona.

Highlights

Oct 17 · PR Newswire
SpliceBio Enters Collaboration with Spark Therapeutics to Develop ... - PR Newswire
Jun 20 · Yahoo Finance
SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program - Yahoo Finance
SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Developmen

Tags

Mutual Connections

See who you know in common with Miquel